The treatment of cancer can impose opportunity costs and these are not necessarily financial. For A crude financial approach would simply be to ask patients how much they would be prepared to pay if. by some means, they could purchase freedom from time spent on treatment. This is unlikely to provide a useful measure of opportunity costs since patients will evaluate any costs in relation to their existing means, and these will vary widely.
The sums allocated would also be strongly influenced by the perceived physical distress associated with treatment and so would not solely reflect opportunity cost. prone to all sorts of biases. and these biases will vitiate anv possible conclusions concerning their attitudes as to what constitutes an acceptable proportion of survival time to be spent on treatment.
The TWiST concept (Goldhirsch et al.. 1989 The opportunitv cost of active treatment should be considered when making decisions concerning the management of patients with cancer: particularly when survival may be short. It is difficult to quantify and its assessment should provide an interesting challenge for future clinical studies.
